McKinsey Future of Asia

• Leading a metabolic health revolution in Asia

  Governments and health systems across Asia aspire to shift toward proactive, preventive care. Yet historically, prevention budgets and policies haven’t matched the rhetoric, leaving reactive treatment models dominant. Today, a new era of change is emerging — from public health initiatives and infrastructure planning to pharmaceutical and wearable-driven innovation — signaling that prevention and treatment are on track to converge for better outcomes. Can Asia become the first region to truly integrate prevention and innovation at scale? In this episode, host Debbi Cheong is joined by Hemant Ahlawat, Senior Partner at McKinsey & Company in Zurich, and Panco Georgiev, Senior Partner in Dubai.See www.mckinsey.com/privacy-policy for privacy information

  --------  

  19:51

  --------

  19:51
• Respect above all: Narayana Murthy’s core business belief

  Narayana Murthy, founder of Indian technology services and consulting giant, Infosys, discusses the vital role that respect and compassion play for him in being a successful business leadSee www.mckinsey.com/privacy-policy for privacy information

  --------  

  21:53

  --------

  21:53
• Exploring the frontier: Technology trends in Asia

  Cutting-edge technologies present exciting possibilities for organizations, but their full potential needs to be unlocked. See www.mckinsey.com/privacy-policy for privacy information

  --------  

  28:06

  --------

  28:06
• Respect above all: Narayana Murthy’s core business belief

  Narayana Murthy, founder of Indian technology services and consulting giant, Infosys, discusses the vital role that respect and compassion play for him in being a successful business leader.See www.mckinsey.com/privacy-policy for privacy information

  --------  

  21:53

  --------

  21:53
• Mazumdar-Shaw’s bold biotech mission: Affordable, accessible healthcare

  Biotech entrepreneurs across Asia are navigating funding gaps, weak innovation ecosystems, and unpredictable regulatory systems. For many, these challenges make it difficult to scale science-led businesses and deliver affordable healthcare solutions. In this episode, host Gautam Kumra, Chairman of McKinsey Asia, sits down with Kiran Mazumdar-Shaw, Founder & Chairperson, Biocon Group. They discuss how she overcame a lack of funding, limited infrastructure, and regulatory hurdles to build one of Asia’s first and most successful biotech companies — pioneering affordable biosimilars, shaping biotech policy in India, and scaling purpose-driven innovation from the ground up. The episode also features McKinsey partner Cheryl SH Lim, and Director of Learning, CEO Institute, Jennifer Chiang.See www.mckinsey.com/privacy-policy for privacy information

  --------  

  33:37

  --------

  33:37

More Business podcasts

Trending Business podcasts

About McKinsey Future of Asia

McKinsey Future of Asia: Podcasts in Family